Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1711)
  2. Journal Article (1446)
  3. Review (84)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (11)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3406)
  2. Solid Tumor Oncology Division (3406)
  3. GSK Faculty (1075)
  4. Department of Pathology and Laboratory Medicine (821)
  5. Hematology-Oncology Fellows (715)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (664)

More Groups

People
  1. Mark Kris (873)
  2. Alexander Drilon (639)
  3. Gregory Riely (606)
  4. Charles Rudin (497)
  5. Marc Ladanyi (419)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (126)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (704)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (159)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (90)

More Publications

Publishers
  1. American Society of Clinical Oncology (783)
  2. Elsevier Inc. (741)
  3. American Association for Cancer Research (387)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (80)

More Publishers

Results (3406)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with non-small cell lung cancer
    Meeting Abstract

    Patel, J.; Spira, A.; Stevenson, J.; Chen, H.; Baik, C.; Gordon, S.; Henry, J. T.; Ahluwalia, M.; Barve, M.; Huang, C.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors
    Meeting Abstract

    Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prospective evaluation of a single-day multidisciplinary clinic for patients with locally advanced non-small cell lung cancer
    Meeting Abstract

    Billing, D. L.; Chaft, J. E.; Jones, D. R.; Daly, R.; Schoenfeld, A. J.; Mueller, B. A.; Preeshagul, I.; Park, B. J.; Iyengar, P.; Gomez, D. R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival after treatment with first-line osimertinib for EGFR-mutant advanced NSCLC in the US
    Meeting Abstract

    Sabari, J. K.; Yu, H. A.; Mahadevia, P.; Liu, Y.; Demirdjian, L.; Sultan, A. A.; Chen, Y. H.; Wang, X.; Passaro, A.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Risk and outcomes of secondary malignancy among non-small cell lung cancer survivors following definitive treatment
    Meeting Abstract

    Yariv, O.; Raoof, S.; Isbell, J. M.; Park, B. J.; Jones, D. R.; Shaverdian, N.; Ruggiero, J.; Jackson, U.; Li, B.; Iyengar, P.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes and immunotherapy retreatment in patients with metastatic NSCLC who complete at least two years of immune checkpoint blockade
    Meeting Abstract

    Ricciuti, B.; Hong, L.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Awosika, N.; Mollica, L.; Citarella, F.; Gandhi, M.; Elkrief, A.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236
    Meeting Abstract

    Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Trial in progress: Phase 1/2 study of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Moyers, J. T.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • A phase II parallel arm study of sacituzumab govitecan-hziy in patients with advanced thymoma and thymic carcinoma
    Meeting Abstract

    Marks, J. A.; Agarwal, S.; Ahn, J.; Reuss, J. E.; Altan, M.; Nabel, C.; Gutierrez, M. E.; Garassino, M. C.; Riely, G. J.; Wakelee, H.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save